Latest News

Microbio says it has developed a new type of COVID-19 test that has the potential to determine not only if someone has the virus but could also indicate whether they are infectious.

IDE Group has announced it will again host the annual 'Building Better Futures for Health Challenge'.

Biosceptre has announced an agreement with The University of Sydney and Children’s Medical Research Institute to establish a new research program on CAR-T cell immunotherapy.

Australian company Immutep (ASX:IMM), which is focused on the development of novel immunotherapy treatments for cancer and autoimmune disease, has been granted a new patent by the European Patent Office.

AnteoTech (ASX:ADO) says it has received the results of an independent validation study of its COVID-19 Antigen Rapid Test using stored patient swab samples.

CSL has announced the winners of their two five-year $1.25 million fellowships, with research investigating new ways to combat health challenges of global significance: cancer and infectious diseases.

Proteomics International Laboratories (ASX:PIQ) has announced it has signed a distribution licensing agreement for the immunoassay version of the PromarkerD predictive test for diabetic kidney disease.

Melbourne-based ASX-listed biotechnology company Amplia Therapeutics (ASX:ATX) will develop a potential new pancreatic cancer therapy discovered by scientists at the Cancer Therapeutics CRC.

Australian oncology-focused biotechnology company Kazia Therapeutics (ASX:KZA) has announced it has executed a definitive agreement with the Global Coalition for Adaptive Research to commence its participation in the GBM AGILE pivotal study in glioblastoma.

Australian company Specialised Therapeutics Australia has updated on a trial of its cancer therapy APLIDIN (plitidepsin) as a potential treatment for COVID-19 infection.

AusBiotech is seeking comment from affected members on two TGA consultations on medical devices: options for introducing a UDI system, and enhancing reporting of adverse effects.

Industry minister Karen Andrews has announced federal government backing for a Brisbane-based manufacturing facility that will produce products for clinical trials.